News
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and oncology, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback